Head-to-head · Value Score
CoreAge Rx vs KERNX Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, KERNX Health a 73. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameKERNX Health
#172 · Grade C+ · Watch List
Est. first month
From $129/mo (plus a separate fee, compounded)
Save ~90% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 73 — an est. $149/mo first month, with no teaser step-up baked in. KERNX Health isn't out of it: Shoppers who want plan pricing published up front and month-to-month billing.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | KERNX Health |
|---|---|---|
| Value Score | 93 (A+) | 73 (C+) |
| Est. first month | $149/mo | From $129/mo (plus a separate fee, compounded) |
| Save vs brand-name | ~89% | ~90% |
| Semaglutide | $149/mo | From $129/mo (plus a separate fee, compounded) |
| Tirzepatide | $349/mo | From $199/mo (plus a separate fee, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
KERNX Health
Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit.
Why it's a deal
- Publishes plan pricing openly, before any intake or account creation
- Month-to-month with no long-term contract and no multi-month prepayment
- Billing starts only after a licensed provider approves treatment
- LegitScript certification verified against the issued seal, not just the badge
The fine print
- Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
- The consultation fee is charged whether or not a prescription is issued
- Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
- No compounding pharmacy is named anywhere on the site
- Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to KERNX Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.